Skip to main content
. 2021 Jun 16;134(13):1610–1615. doi: 10.1097/CM9.0000000000001492

Figure 2.

Figure 2

Comparison of serum CXCL13 at each time point between groups. CON: Group control; CXCL-13: C-X-C motif chemokine ligand; 13; EDA: Group edaravone.